CLINICAL RESEARCH
Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality
Abhiram Prasad, MD, FRCP, FACC*,*,
Mandeep Singh, MD, FACC*,
Amir Lerman, MD, FACC*,
Ryan J. Lennon, MS ,
David R. Holmes, Jr, MD, FACC* and
Charanjit S. Rihal, MD, FACC*
* Division of Cardiovascular Diseases, Department of Internal Medicine
Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Manuscript received January 13, 2006;
revised manuscript received April 20, 2006,
accepted April 23, 2006.
* Reprint requests and correspondence: Dr. Abhiram Prasad, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905 (Email: prasad.abhiram{at}mayo.edu).
OBJECTIVES: The aim of this study was to evaluate whether, in patients with normal post-procedure CK-MB, an isolated elevation in cardiac troponin T (cTnT) predicts long-term survival.
BACKGROUND: Cardiac troponin T is a sensitive and specific marker of myonecrosis. There is little known about the incidence and prognostic significance of an isolated elevation of cTnT without a rise in creatine kinase (CK)-MB following PCI.
METHODS: We evaluated the outcomes of 1,949 patients from the Mayo Clinic registry who had normal pre-procedure cTnT and CK-MB, required nonemergency percutaneous coronary intervention (PCI), and had normal CK-MB after the procedure.
RESULTS: An elevation in cTnT (cTnT+) was observed in 383 patients (19.6%) (median 0.04 ng/ml, interquartile range 0.03 to 0.06 ng/ml). The TnT+ status was associated with adverse clinical and angiographic characteristics, and multivessel PCI. Over the median follow-up duration of 26 months, mortality (p < 0.001) and the combined rate of death and myocardial infarction (p = 0.004) were significantly higher in cTnT+ patients. Estimated 3-year survival for those with and without cTnT elevation was 86.9% and 93.2%, respectively. By multivariate analysis, an elevation in cTnT after PCI was an independent predictor of increased long-term mortality. A doubling in the post-PCI cTnT was associated with a partial hazard ratio of 1.20 (95% confidence interval 1.02 to 1.40; p = 0.023).
CONCLUSIONS: An isolated minor elevation in cTnT after PCI provides long-term prognostic information regarding mortality and myocardial infarction.
|
Abbreviations and Acronyms
| | CABG = coronary artery bypass graft | | CK-MB = creatine kinase-MB | | CRP = C-reactive protein | | cTnT = cardiac troponin T | | MI = myocardial infarction | | PCI = percutaneous coronary intervention |
|
Related Article
-
Measuring Troponin Elevation After Percutaneous Coronary Intervention: Ready for Prime Time?
- Neal S. Kleiman
J. Am. Coll. Cardiol. 2006 48: 1771-1773.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
K Rahimi, A P Banning, A S H Cheng, T J Pegg, T D Karamitsos, K M Channon, S Darby, D P Taggart, S Neubauer, and J B Selvanayagam
Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study
Heart,
December 1, 2009;
95(23):
1937 - 1943.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel
Coronary Microembolization: From Bedside to Bench and Back to Bedside
Circulation,
November 3, 2009;
120(18):
1822 - 1836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J.E. Sattler, J. Herrmann, S. Yun, N. Lehmann, Z. Wang, G. Heusch, S. Sack, R. Erbel, and B. Levkau
High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention
Eur. Heart J.,
August 1, 2009;
30(15):
1894 - 1902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Testa, W.J. Van Gaal, G.G.L. Biondi Zoccai, P. Agostoni, R.A. Latini, F. Bedogni, I. Porto, and A.P. Banning
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition
QJM,
June 1, 2009;
102(6):
369 - 378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Popma, L. Mauri, C. O'Shaughnessy, P. Overlie, B. McLaurin, A. Almonacid, A. Kirtane, and M. B. Leon
Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents
Circ Cardiovasc Interv,
April 1, 2009;
2(2):
133 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y. Fung, J. Saw, A. Starovoytov, C. Densem, P. Jokhi, S. J. Walsh, R. S. Fox, K. H. Humphries, E. Aymong, D. R. Ricci, et al.
Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial.
J. Am. Coll. Cardiol.,
March 10, 2009;
53(10):
837 - 845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Cuisset, C. Frere, J. Quilici, P.-E. Morange, J.-P. Mouret, L. Bali, P.-J. Moro, M. Lambert, M.-C. Alessi, and J. L. Bonnet
Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders: A Prospective, Randomized Study
J. Am. Coll. Cardiol. Intv.,
December 1, 2008;
1(6):
649 - 653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pocar, F. Donatelli, A. Moneta, H. Tomoda, J. A. Tayek, J. R. Arnold, A. P. Banning, S.-J. Park, D.-W. Park, and Y.-H. Kim
Stents versus Bypass Grafting for Left Main Coronary Artery Disease
N. Engl. J. Med.,
July 24, 2008;
359(4):
423 - 425.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Cuisset, M. Hamilos, N. Melikian, E. Wyffels, J. Sarma, G. Sarno, E. Barbato, J. Bartunek, W. Wijns, and B. De Bruyne
Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation.
J. Am. Coll. Cardiol.,
March 18, 2008;
51(11):
1060 - 1065.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Schiano and P. Gabriel Steg
Measurement and prevention of myocardial injury during percutaneous coronary intervention
Heart,
June 1, 2007;
93(6):
656 - 657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Cutlip, S. Windecker, R. Mehran, A. Boam, D. J. Cohen, G.-A. van Es, P. Gabriel Steg, M.-a. Morel, L. Mauri, P. Vranckx, et al.
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Circulation,
May 1, 2007;
115(17):
2344 - 2351.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Isolated cTnT Elevation After PCI
Journal Watch Cardiology,
December 6, 2006;
2006(1206):
3 - 3.
[Full Text]
|
|
|
|
|
|
|
N. S. Kleiman
Measuring Troponin Elevation After Percutaneous Coronary Intervention: Ready for Prime Time?
J. Am. Coll. Cardiol.,
November 7, 2006;
48(9):
1771 - 1773.
[Full Text]
[PDF]
|
|
|
|
